Phase II Open-Label Pilot Study of V3381 in Chronic Cough
Phase II Open-label Pilot Study of V3381, a Novel N-Methyl-D-Aspartate Receptor Antagonist, in Chronic Cough Patients Attending a Specialist Clinic
Sponsor: Manchester University NHS Foundation Trust
Terminated
Lack of efficacy
Other terminated trials from Manchester University NHS Foundation Trust
- Pregnancy · Phase PHASE4 · May 2018
- Abdominal Aortic Aneurysm · Phase NA · May 2014
- Hemophilia A With Inhibitors · Phase NA · Dec 2012
See all terminations from Manchester University NHS Foundation Trust
Other Cough trials with similar outcome
A PHASE2 clinical study on Cough, this trial is terminated or withdrawn. The trial is conducted by Manchester University NHS Foundation Trust and has accumulated 6 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE2
-
Feb 2018 — Jun 2018 [monthly]
Terminated PHASE2
▶ Show 1 earlier version
-
Jan 2017 — Feb 2018 [monthly]
Terminated PHASE2
First recorded
Oct 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Manchester University NHS Foundation Trust
- Vernalis (R&D) Ltd
For direct contact, visit the study record on ClinicalTrials.gov .